Target cell UBER enzymes mediate the detection and cleavage of A3G-edited HIV-1 cDNA. To test whether UDGs, specifically UNG2 39, 40 , mediate the processing of uridine-containing cDNA, leading to endonucleolytic cleavage, we used the bacteriophage uracil-DNA glycosylase inhibitor (UGI) 41 . CEM-SS target cells and HEK293T producer cells stably expressing codon optimized UGI (hUGI) 25 were generated, the latter being required because UNG2 is packaged into virions 42, 43 . Enzymatic analyses of cell lysates confirmed efficient UDG suppression ( Supplementary Fig. 6 ). HIV-1Δ Vif was produced in control or hUGI-expressing HEK293T cells in the absence or presence of A3G ( Fig. 2a ). In bulk measurements of virus infectivity and cDNA abundance (Fig. 2b,c) , no differences were attributable to hUGI, irrespective of expression in producer, target or both cultures, reconfirming that UNG2 inhibition does not impact A3G antiviral function [25] [26] [27] . Sequencing analysis revealed that UNG2 inhibition in target cells mitigated A3G's induction of foreshortened cDNAs, with the overall profiles of 3′ -termini resembling those seen without A3G ( Fig. 2d and Supplementary Fig. 7) .
We therefore conclude the following: (1) target cell UNG2 can detect A3G-edited cDNAs, leading to uracil removal and subsequent cleavage (Fig. 1a , pathway 2); (2) UBER-mediated cDNA fragmentation does not lead to their complete degradation, implying that a deamination-independent mechanism probably underlies the inhibition of cDNA accumulation by A3G; and (3) A3G does not induce site-specific RT pausing, thus arguing against the aforementioned 'roadblock' mechanism for RT inhibition.
Interaction between A3G and the HIV-1 RT heterodimer. The 3′ -termini profiles seen in the absence of A3G, in its presence but with UNG2 activity abrogated, or with catalytically inactive A3G mutants are very similar to each other, yet levels of cDNA production differ substantially. One model to reconcile these observations is for A3G to affect RT processivity through a mechanism that lacks template sequence specificity. This would yield similarly reduced nucleotide addition efficiency at all positions, regardless of RT location on the template RNA. We hypothesized that this could be achieved through A3G interacting with RT and inhibiting its enzymatic capability.
To evaluate this model, we initially used lysates from transfected HEK293T cells to confirm that A3G co-immunoprecipitates with the HIV-1 RT heterodimer (p51 and p66 subunits) ( Fig. 3a) 31 . Because A3G and RT are RNA-binding proteins, we used several techniques to ensure that this interaction is not simply bridged by RNA. First, co-immunoprecipiation assays were performed in the presence of ribonucleases (Fig. 3b ). Although either a heterogeneous RNase mixture (upper panels) or RNase A (lower panels) noticeably reduced the amount of recovered A3G, the effect was saturable, with A3G pulldown still remaining clear at high RNase levels.
We next carried out surface plasmon resonance (SPR) assays using purified p51 and A3G, both stripped of nucleic acids ( Supplementary Fig. 8 ). Measurements provided association and dissociation curves that gave acceptable fits to a single interaction model ( Fig. 3c ), suggesting that the majority of complexes were homogeneous in nature. The association rate constant (k on ) was calculated to be 1.4 × 10 3 M −1 s −1 and the dissociation rate constant (k off ) 2.2 × 10 −3 s −1 , yielding a dissociation constant (K d ) of ~1.6 μ M, a value close to that calculated using rotational anisotropy (2.3 μ M) 44 . Curve fitting indicated a maximal binding (B max ) of ~200 RU (resonance units) of p51. Because the A3G ligand surface density is ~200 RU, this is consistent with a 1:1 binding stoichiometry for the A3G-p51 complex. Taken together, these findings indicate that A3G and RT interact directly and that RNA may help to stabilize the complex.
Using cell-based FRET assays to measure the A3G-RT interaction.
To address further the direct or indirect nature of the A3G-RT interaction, we turned to fluorescence resonance energy transfer (FRET) assays as they circumvent any need for protein purification or enrichment. Specifically, we used green fluorescent protein (GFP, the donor) and mCherry (the acceptor) fusion proteins, coexpressed in HeLa cells, together with fluorescence lifetime imaging NATURE MICROBIOlOGy microscopy (FLIM) for the FRET readout. Here, the average lifetime τ of the donor is reduced when in a FRET state owing to the proximity of the acceptor (Supplementary Methods) 45 . FRET is shown both as representative pseudocoloured images (with blue/ green indicating longer τ than yellow/red colours; Fig. 3d ,e) and as efficiency percentages (Fig. 3f ). Fig. 4b ) within each sample to show the relative abundance of cDNAs for each length between nt positions 23 and 182. Shown in dashed red lines are the percentages of reads carrying C to T/U mutations at that position (scale on the right y axes). See Methods for analysis details. One representative experiment from three independent repeats is shown.
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Cells were transfected with vector pairs expressing the indicated fusion proteins, then fixed, and analysed after 24 h. As expected, A3G_GFP localized to P-bodies, stress granules, as well as the cytosol, while the RT subunits were more evenly distributed across the cytoplasm (Fig. 3d,e ). The oligomerization of A3G [46] [47] [48] and hetero-dimerization of RT subunits provided positive controls, each visualized as yellow/orange colouration ( Fig. 3e , top row, and Fig. 3f ). The RNA helicase MOV10, which co-localizes to P-bodies with A3G, but is not thought to interact with A3G directly because co-immunoprecipitation depends on RNA bridging 49 , served as a negative control. No change in donor τ was observed, consistent with the lack of a direct A3G-MOV10 interaction. The low FRET efficiency displayed between A3G_GFP and the oligomerization-deficient W127A_mCherry mutant 50 provided further assay validation( Fig. 3e, second showing increasing amounts of packaged A3G_HA at constant CA levels for virions produced in the presence or absence of a codon optimized (humanized) uracil-DNA glycosylase inhibitor (hUGI). 'Low' or 'High' A3G refers to producer cell transfection ratios of 1:10 or 1:1, respectively (A3G expression plasmid to NL4.3/Δ Vif). One of three independent virus preparations, which were used for b and c, is shown. b, Virion infectivity was evaluated by challenging TZM-bl target cells and measurement of β -galactosidase activity. c, The abundance of (-)sss cDNA in CEM-SS target cells at 4 h post-infection was measured by qPCR. For b and c, three independent sets of viral preparations were used to infect TZM-bl or CEM-SS target cells with or without hUGI (black circles and grey squares, respectively). Individual data points and their mean and standard deviation for each viral preparation and infection are shown. d, Sequencing reads from a MiSeq library run were analysed and presented as in Fig. 1g . Labelling to the right indicates whether the HEK293T producer cells (Prod.) and/or the CEM-SS target (Target) cells expressed hUGI. No A3G indicates the absence of A3G in producer cells, and high A3G refers to relative A3G content in the producer cells. Sequencing data are derived from one representative experiment from two independent repeats.
yielded marked reductions in τ, demonstrating very close proximity between RT subunits and A3G ( Fig. 3e , third row), consistent with a direct protein-protein interaction.
A3G and RT interact within intact HIV-1 virions.
We also adapted our FRET-FLIM system for cell-free, bulk HIV-1 particles ( Fig. 4 ). A3G_GFP was packaged into virions by co-expression with HIV-1Δ Vif and these were purified and immobilized on coverslips, before immunostaining and FRET analysis. Rather than using protein fusions that could interfere with viral assembly or particle maturation, RT was detected using a Cy3-labelled anti-RT Fab fragment. A3G_GFP exhibits a normal GFP lifetime in the absence of a fluorescent acceptor (Fig. 4a) , and a positive control of co-packaged A3G_GFP and A3G_mCherry demonstrates the suitability of this Transfected HEK293T cell lysates were subjected to anti-FLAG immunoprecipiation, and recovered proteins were detected with anti-HA (for A3G), anti-RT or anti-FLAG antibodies. CD8_FLAG served as an irrelevant protein control. One representative experiment of three repeats is shown. *HC: immunoglobulin heavy chain b, RNase resistance of the A3G-RT complex. Shown are anti-FLAG immunoprecipitations after the bead-bound proteins had been subjected to RNase A or RNase Mix treatment, at the indicated concentrations, followed by washing and immunoblotting. One representative experiment of three repeats is shown. Samples without RT_FLAG carry CD8_FLAG as an irrelevant tagged protein control. c, Surface plasmon resonance analysis of purified A3G and p51 on a Biacore T-200 instrument. Association and dissociation curves of p51_FLAG to immobilized A3G_6xHis at the indicated concentrations are shown. The sensorgram indicates specific binding between the two components and the responses gave good fits to a single interaction binding model with a K d of ~1.6 μ M. d-f, Measurements of FRET efficiency using FLIM in HeLa cells expressing GFP and mCherry fusion proteins. White scale bars, 10 μ m. Representative images with GFP fluorescence from multiphoton laser scanning microscopy (d and e, left panels) and corresponding wide-field CCD camera images of mCherry fluorescence (e only, right panels) are shown. Pseudo-coloured images show GFP lifetime τ (blue/green, normal/longer GFP lifetime; yellow/red, shorter GFP lifetime indicating FRET). In d, control images demonstrate normal GFP lifetime in the absence of mCherry acceptor. In e, co-expression of indicated GFP and mCherry fusion proteins and the fluorescence lifetime according to the scale in d indicate the presence or absence of FRET. In f, a dot plot presents FRET efficiencies with mean and standard deviation (n = 7 cells each).
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assay for detecting protein-protein interactions within virions ( Fig. 4b , left panel, top row, and Fig. 4c ). A substantial increase in FRET efficiency was evident when RT was detected with labelled Fab (Fig. 4b , bottom right row, and Fig. 4c ), which was not seen with other packaged proteins as acceptors (Vpr_GFP or cyclophilin A_GFP), the antibody-mediated detection of Capsid protein (p24 Gag ) ( Fig. 4b , top right rows, and Fig. 4c ), or for virions engineered to lack RT ( Fig. 4b , left bottom row). These data demonstrate that A3G and RT interact in viral particles and support the view that A3G is positioned at the site of reverse transcription.
Regions of A3G that interact with HIV-1 RT.
Regions of A3G that interact with RT were mapped by co-expression of RT with a set of A3G-glutathione-S-transferase (GST) fusions and co-immunoprecipitation ( Fig. 5a ). Consistent with earlier results 31 , full-length A3G and a fragment spanning residues 65-132 interacted with RT (lanes 3 and 4). Interestingly, the N-terminal 76-amino-acid fragment of A3G also bound RT (lane 5), with further truncations revealing a dependency on the residues between positions 30 and 42 (lanes 7 and 8). Thus, RT interacts with two discrete and nonoverlapping regions of A3G.
Double alanine scanning mutagenesis between residues 30 and 42 in the context of full-length A3G showed that a W34A/L35A double mutant and subsequently the single L35A mutant were impaired for interacting with RT ( Fig. 5b ). These mapping data were confirmed in intact cells, as the substitution of leucine at position 35 with alanine (W34A/35A and L35A mutants) significantly reduced FRET efficiency ( Fig. 5c , rows 3 and 4, and Fig. 5d ). As a control, the R24A mutation in A3G, which disrupts a positively charged patch at the A3G dimer interface 51 and inhibits RNA binding 50 ( Supplementary Fig. 3c ), was shown not to alter binding to RT ( Fig. 5b-d) , thereby reinforcing the conclusion that the A3G-RT interaction is RNA-independent. Importantly, like R24A 50 , the L35A protein maintains full enzymatic activity, as measured in an Escherichia coli-based DNA editing assay ( Supplementary Fig. 9 ), indicating that these substitutions do not cause global structural defects or misfolding.
Inhibition of the RT interaction diminishes A3G antiviral activity.
Derivation of a mutation in A3G that interferes with RT binding but maintains deaminase function allowed us to evaluate directly the importance of the A3G-RT interaction for antiviral activity. The L35A protein, similar to R24A 50 , is not packaged into viruses as efficiently as wild-type A3G. However, this defect is partial and is overcome by increasing protein expression in virus producer cells.
For these experiments, we used titrations of wild-type A3G in producer cells to yield viruses with a range of packaged A3G levels ( Fig. 6a and Supplementary Fig. 10a ). These stocks were then used to infect TZM-bl cells to determine overall infectivity ( Supplementary Fig. 10b ) and CEM-SS cells to measure cDNA production ( Supplementary Fig. 10c ), and fitted curves were generated that related infectivity or cDNA levels to amounts of packaged A3G ( Supplementary Fig. 10d,e ).
Viruses carrying the L35A or R24A mutants were prepared in parallel and analysed for packaging, infectivity and cDNA production. By extrapolation along the fitted curves, we compared their effects on infectivity ( Fig. 6b ) and reverse transcription ( Fig. 6c ) with those of wild-type A3G at matched packaging levels. Over eight experiments, L35A was significantly less antiviral than A3G, and this was 
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coupled with increased cDNA production. Critically, R24A displayed equivalent antiviral activity to wild-type A3G at comparable levels of encapsidation, thus phenotypically distinguishing itself from L35A. Moreover, the finding that R24A still suppresses reverse transcription ( Fig. 6c ), while binding RNA less well ( Supplementary  Fig. 3 ) 50 , is again consistent with RT suppression not being mediated by the 'roadblock' mechanism.
To test whether the remaining antiviral activity of L35A is deaminase dependent, we combined this change with a mutation, C288S, that ablates deamination but incompletely prevents antiviral activity ( Fig. 6d and Supplementary Figs. 5 and 10g,h) 27, 28 . Importantly, the double mutant (C288S/L35A) displayed a total loss of antiviral function, even at high expression levels ( Fig. 6d ), underscoring the importance of both attributes for full A3G activity.
Finally, we analysed the cDNA profiles in CEM-SS cells challenged with HIV-1Δ Vif lacking A3G or containing similar levels of wild-type A3G, R24A or L35A ( Fig. 6a,e ). The three profiles obtained with A3G-bearing viruses were essentially identical, confirming the editing competency of these mutant proteins and the absence of any site-specific pausing that correlated with inhibited cDNA synthesis. We therefore conclude that A3G regulates HIV-1 RT through a direct interaction that impedes enzymatic capability and suppresses the production of DNA evenly and without sequence or site specificity (Fig. 1a, pathway 3 ).
Discussion
Here, we present a custom method for monitoring the progression of HIV-1 reverse transcription at single nucleotide resolution in infected cells. Our findings have relevance for understanding not only A3-mediated restriction, but also fundamental aspects of reverse transcription. In particular, much of the current knowledge of reverse transcription has been obtained using in vitro reconstituted systems 32, 33, 52, 53 (for example, Supplementary Fig. 3 ). In agreement with such studies, we demonstrate a marked accumulation of a predominant (-)sss species (for example, Fig. 1g ) 34, 54, 55 , yet defining its precise 3′ -terminus has previously been elusive. The abundant (-)sss cDNA we detect has a single 3′ -cytidine (nt position 180) and we presume this to be derived from the Cap G1-form of HIV-1 RNA. This is consistent with the preferential dimerization and packaging of Cap G1 RNA that has a single guanosine at its 5′ -terminus, rather than the Cap G2-or Cap G3-forms, which contain two or three 5′ -guanosines 56, 57 .
In contrast to the distinctive (-)sss product seen in living cells and reconstituted systems, the foreshortened cDNAs that are detected in reconstitution experiments are negligible in infected cells ( Fig. 1g and Supplementary Fig. 3 ). Their formation has been ascribed to RT pausing/arrest at homopolymeric motifs or RNA secondary structures [34] [35] [36] 58 . These reproducible disparities may reflect variations in the enzymatic capabilities of HIV-1 RT in the microenvironment of reverse transcription complexes in infected cells versus Cell lysate Anti-GST (A3G) showing relative amounts of packaged wild-type or mutant A3G_HA at constant CA levels. Ratios refer to the amounts of transfected A3G expression plasmid and proviral plasmid during virus production. b, A3G-L35A, but not A3G-R24A, displays diminished HIV-1 inhibitory activity. A3G packaging was quantified by immunoblot density measurements and the different wild-type A3G packaging levels were plotted versus measured infectivity. The extent of infection inhibition exerted by the wild-type protein at the empirically determined level of packaged mutant protein was then extrapolated ( Supplementary  Fig. 10 ). Inhibition levels, in % relative to the no A3G control, of wild-type A3G and L35A or R24A (mutant A3G) in eight (L35A) or seven (R24A) independent experiments are shown. A paired, two-tailed student t-test was performed in GraphPad Prism . *P < 0.05 (P = 0.0223); NS, not significant. c, As in b, but with (-)sss cDNA abundance measured by qPCR in cells 4 h post-infection for virions carrying wild-type or mutant A3G. **P < 0.005 (P = 0.0028). d, Relative infectivity of n = 5 independent virus preparations carrying the indicated wild-type or mutant A3G at equal, 'high' levels, as shown in the representative immunoblot in Supplementary Fig. 10g . A paired, two-tailed student t-test was performed in GraphPad Prism. *P < 0.05 (P = 0.0397 for A3G wt -L35A; P = 0.0297 for C288S -C288S/L35A; P = 0.0137 for L35A -C288S/L35A). e, Sequencing reads from a MiSeq library run were analysed and presented as in Fig. 1g . Labels to the right indicate the presence or absence of A3G proteins in virions.
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in reconstituted reactions; differences in the formation of viral genomic RNA secondary and tertiary structures; or the presence or relative abundance of viral (or host) proteins such as the HIV-1 nucleocapsid protein at the site of reverse transcription.
Not surprisingly, experimental system-dependent differences extend to the effects of A3G on reverse transcription. Studies with reconstituted assays have previously indicated A3G-induced pausing of RT at specific sites 22 (Supplementary Fig. 3a ), which helped formulate the 'roadblock' model. Critically, our cell-based DNA sequencing approach provided no evidence for localized A3Ginduced RT pausing, with the prominent A3G-dependent cDNA peaks being caused by UBER activity (Fig. 2) . These findings evoke a sequence-and site-independent mechanism for the suppression of RT by A3G and imply the following: (1) there are differences in the behaviour of RT in the context of HIV-1 infection and (2) the A3G-induced pausing that is seen in reconstituted reactions reflects an assay-specific epiphenomenon.
Intrinsic to our model for A3G function is its negative regulatory interaction with RT, which, based on a series of corroborating biochemical, biophysical and cell-based FRET assays (Figs. 3-5) 31 , we consider to be dependent on direct binding. Purposeful interference with this interaction through replacement of leucine-35 resulted in a significant loss of antiviral activity (Fig. 6b,c) , with the remaining antiviral activity of L35A being attributable to its deaminase function, given that the C288S/L35A double mutant displayed a complete loss of antiviral phenotype (Fig. 6d ).
Our sequencing approach also allowed us to examine the effects of UBER on viral cDNA following exposure to A3G. Although we reveal UNG2-mediated uridine excision from deaminated cDNA, our measurements show ensuing endonucleolytic cleavage is far from complete, because substantial proportions of cytidine-to-uridine edited cDNAs remained intact (Figs. 1, 2 and 6 ). Appreciating this inefficiency helps to reconcile the apparent discrepancy between the predicted degradative fate of deaminated cDNAs (Fig. 1a , mechanism 2) and the lack of persuasive evidence for UDG involvement in A3G function. Nevertheless, despite the absence of an evident antiviral effect in single-round infections (Fig. 2b) , inefficient UBER recognition of edited cDNA could still play a role in the interplay between HIV-1 and infected cells, for instance through sensing of aberrant cDNA fragments as a pathogen-associated molecular pattern 1, 59 . How HIV-1 may circumvent this (aside from Vif-induced A3 destruction in virus-producing cells) is a matter of conjecture, but we note that HIV-1 Vpr and its interacting CUL4 ubiquitin ligase induces UNG2 degradation 23, 43, 60 .
Uracilation of HIV-1 cDNA can also arise from the misincorporation of dUTP in place of dTTP during reverse transcription 61 , especially in non-dividing cells such as macrophages that have high dUTP:dTTP ratios 62, 63 . UNG2-mediated recognition of the resulting uracilated viral cDNA suppresses infection, with restriction being most evident at the level of DNA integration [64] [65] [66] [67] . Interestingly, and in contrast to observations made with A3G-induced uracilation ( Fig. 2 and Supplementary Fig. 7 ) [25] [26] [27] , UGI-mediated suppression of UNG2 in the face of misincorporation-driven uracilation provokes viral rescue 64, 65 . The basis for this dichotomy remains to be determined, but could relate to variations in the extent of uracilation, or cell-type-dependent differences in the efficiency of UBER-mediated cDNA recognition or the fate/processing of uracilated cDNA.
Reverse transcription is a vulnerable step in the HIV-1 life cycle: it is highly susceptible to pharmacological inhibition and is also suppressed by A3G and other host cell restriction factors. TRIM5α destabilizes post-entry viral capsids, which compromises the timely onset/completion of reverse transcription [68] [69] [70] , while the deoxynucleotide triphosphohydrolase SAMHD1 interferes with reverse transcription by depleting cellular dNTP pools 2 . In contrast to these indirect mechanisms, we demonstrate that RT is inhibited by A3G by a distinct mechanism, namely via a direct protein interaction that impedes biosynthetic activity. Establishing the concept that HIV-1 RT can be negatively regulated in this manner raises the possibility that additional cellular factors may modulate RT 71 .
Future directions for this work include determining how A3G binding to RT interferes with enzymatic function, how leucine-35 (a residue that is highly conserved within the A3 family) participates in the RT interaction, and which regions of RT bind to A3G. Elucidating the macromolecular structure of the A3G-RT complex will naturally be a major advance and can assist in resolving the heretofore elusive structure of full-length A3G 72 . Finally, by revealing that a non-virally encoded interacting partner can regulate HIV-1 RT, we highlight a previously unrecognized vulnerability in the enzyme that may have the potential to be targeted therapeutically.
Methods
Plasmid constructs. The expression vector for Vif-deficient HIV-1 NL4.3 has been described previously 15 . Wild-type and mutant A3G proteins carrying the carboxy-terminal 3xHA tag were expressed using pCMV4_HA 50, 73 . Site-directed mutagenesis was carried out based on the QuikChange protocol (Stratagene) using Pfu polymerase (Stratagene). Transfer plasmids for the generation of recombinant baculovirus were generated as follows: wild-type or mutant A3G sequences were PCR-amplified and cloned into pCGTHCF FL T7 with a carboxyterminal 6xHis tag sequence using XbaI and AgeI restriction sites. The tagged A3G insert was subsequently PCR-amplified and inserted into the pVL1392 transfer vector (BD Biosciences) using EcoRI and XmaI restriction sites. Expression vectors for HIV-1 RT p51 and p66 were created as follows: a codon optimized gag-pol plasmid (pCO Gag-pol 74 ) was used as the PCR template and fragments were subcloned into pCAGGS using XmaI/NotI (p51) or EcoRI/ XmaI (p66). The reverse primers were designed with or without a 1xFLAG tag coding sequence. Expression vectors encoding truncated A3G proteins with amino-terminal GST tags were generated by PCR amplification and subcloned into pCAGGS_GST with EcoRI/XhoI. Fluorescent protein fusions were expressed from plasmid constructs carrying the respective cDNA sequence from the aforementioned vectors and subcloned in pEGFP_N1 (Clontech) and pmCherry_N1 (Clontech) vectors. The cDNA for the (human) codon optimized uracil-DNA glycosylase inhibitor (hUGI) gene was a gift from M. Emerman 25 and was subcloned into the MLV-based transfer vector pCMS28 75 . MLV packaging and VSV-G expression vectors have been described previously 8 .
Cell lines and stable cell lines. HEK293T and HeLa cells were obtained from ATCC. TZM-bl cells were obtained through the NIH AIDS Reagents Repository Program (ARRP). Cells were cultured in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 10% fetal bovine serum and 1% penicillin/ streptomycin. CEM-SS cells, also from ARRP, were cultured in Roswell Park Memorial Institute (RPMI) 1640 medium (Invitrogen) supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin. All cells were tested and found to be negative for mycoplasma contamination. hUGI-expressing HEK293T, CEM-SS and TZM-bl cells were created using standard MLV-based transduction vectors. HEK293T cells were co-transfected with expression plasmids for VSV-G, an MLV packaging plasmid and pCMS28 encoding hUGI. Transduced cells were selected with 1 μ g ml -1 puromycin.
Virion production. HEK293T cells were seeded in 10 cm tissue culture plates and co-transfected with 10 μ g pNL4.3/Δ Vif and 0.25-10 μ g pCMV4_A3G_HA wild-type or mutant expression vectors using polyethylenimine (PEI, Molecular Biosciences). Total DNA levels were kept constant with empty pCMV4-HA vector. At 48 h, supernatants were collected, DNAse (RQ1 RNase free DNAse; Promega) treated for 1 h at 37 °C, and viruses then purified through a 20% (wt/vol) sucrose cushion at 28,000g for 75 min at 4 °C. Viruses were resuspended in PBS, and quantified according to p24 Gag content using an enzyme-linked immunosorbent assay (ELISA; Perkin-Elmer).
TZM-bl reporter assay. TZM-bl reporter assays were used to measure singlecycle HIV-1 infectivity. Virus inputs equivalent to 10 or 20 ng p24 Gag were used to challenge 0.5 × 10 5 cells in a 48-well format. At 48 h post infection, whole-cell lysates were assayed for the induction of β -galactosidase expression using a Galacto-Star system (Applied Biosystems).
Infections. CEM-SS T cells were seeded at 1 × 10 6 cells per 0.5 ml of medium in a 12-well format. Virus equivalent to 75 ng p24 Gag was added and the cells were spin-infected at 2,000g for 2 h at 30 °C. After centrifugation, cells were left to recover for 1 h in the incubator, before two washes with PBS to remove the inoculum. Cells were maintained in fresh medium for 1 h before being collected by centrifugation, and pellets were either frozen at − 80 °C or immediately processed for DNA extraction.
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DNA extraction and quantitative real-time PCR. Whole-cell DNA was isolated using the DNAeasy Blood and Tissue Kit (Qiagen) according to the manufacturer's protocol. DNA was eluted with 200 μ l H 2 O. Volumes of 17.5 μ l were mixed with 2 μ l Cutsmart buffer (NEB) and 0.5 μ l DnpI (NEB) (to eliminate any remaining transfected plasmid) for 1 h at 37 °C before analysis by qPCR. The remaining nucleic acid fraction was reserved for library preparation. Early reverse transcription products were detected using primers that amplify the region between nt 500 and 635 of the provirus: oHC64 (5′ -taactagggaacccactgc-3′ ) and oHC65 (5′ -gctagagattttccacactg-3′ ) and probe oHC66 (5′ -FAMacacaacagacgggcacacacta-TAMRA-3′ ). Reactions were performed in duplicate, in TaqMan Universal PCR master mix (no AmpErase), using 0.9 pmol of each primer per μ l and 0.25 pmol probe per μ l. After 10 min at 95 °C, reactions were cycled through 15 s at 95 °C, followed by 1 min at 60 °C for 40 repeats, carried out on an ABI Prism model 7900HT (Applied Biosystems). pNL4.3/Δ Vif, was diluted in herring sperm DNA to generate a standard curve. Statistical analysis. Where indicated, a paired or unpaired, two-tailed t-test was carried out using the t-test function in GraphPad Prism 6.0.
MiSeq library preparation. Enrichment for HIV-1-specific sequences.
Whole-cell DNA from infected cells was isolated as above and HIV-1-specific DNA was enriched over the genomic DNA. Biotinylated oligonucleotides complementary to the HIV-1 sequence (within the tRNA primer and within the first 22 nt of the strong stop sequence; see exact sequences below) were annealed to the cDNA sample, and a pulldown with magnetic strepdavidin beads was performed. For each sample, 100 μ l strepdavidin beads (Promega, Magnasphere Z5481) were washed (using a magnet) with 100 μ l of bind and wash buffer (BW: 5 mM Tris pH 7.5, 0.5 mM EDTA, 1 M NaCl) then blocked for 10 min in casein solution at room temperature and again washed once in BW buffer. Beads were resuspended in BW buffer containing 50 pmol 5′ -cagtgtggaaaatctctagcag-biotin-3′ , 5′cagtggcgcccgaaca-biotin-3′ and 5′ -biotin-cagtgtggaaaatctctagcagtggcgcccgaacagg gac-biotin-3′ . The mixture was left for 30 min at room temperature while rotating. Beads were then washed twice in 1xTEN buffer (10 mM Tris HCl pH 8.0, 1 mM EDTA, 100 mM NaCl) and then resuspended in 10 μ l TEN buffer. This was added to 170 μ l DNA and 90 μ l 3xTEN. Samples were denatured at 92 °C for 2 min and incubated at 52 °C for 1 h. Finally, beads were washed once with 1xTEN buffer and resuspended in 50 μ l H 2 O. To elute the DNA, samples were heated to 92 °C for 2 min, put on the magnet, and the supernatant removed quickly.
Adaptor ligation. The barcoded adaptor carries a 5′ phosphate group (PHO) and a 3′ three-carbon chain (C3) spacer (SpC3) onto the 3′ hydroxyl group (5′ -PHO-tgaagagcctagtcgctgttcannnnnnctgcccatagagagatcggaagagcacacgtct-SpC3-3′ ) (Integrated DNA Technologies or MWG Eurofins) and was self-annealed in T4 DNA ligase buffer by heating to 92 °C followed by slow cooling to 16 °C (2% slope on Eppendorf PCR machine). Ligation reactions were set up in a 60 μ l total volume, with 6 μ l T4 DNA ligase buffer, 24 μ l 50% PEG-8000 (Sigma), 6 μ l 5 M betaine (Sigma), 4 μ l pre-annealed adaptor (400 pmol total), 1.2 μ l T4 DNA ligase (NEB, 2,000,000 units ml −1 ) and 18.8 μ l DNA sample. Reactions were incubated at 16 °C overnight. As controls, instead of DNA samples, HTP control oligos (listed in Supplementary Fig. 2 ) at 100 pmol μ l -1 were mixed at equimolar ratios and then diluted 1 in 62,500 before being ligated as above.
Adaptor removal and size selection. Ligations were denatured by adding 30 μ l gel loading buffer II (Ambion, formamide buffer) and heating for 2 min at 94 °C before being put on ice. 6% TBE ((Tris/Borate/EDTA) at 89 mM Tris-base, 89 mM boric acid, 2 mM EDTA) urea gels (precast, Life Technologies) were prerun in 1xTBE buffer for ~15 min at 250 V and each sample was loaded into three adjacent wells. Gels were run for 20 min at 250 V before gel strips containing samples were immersed in 1xTBE and SYBR Gold (Thermo Fisher). To avoid crosscontamination between samples during staining and gel cutting, a maximum of two samples were run per gel and gels were cut for separate staining. After 5 min, DNA was visualized on a visible blue-light LED transilluminator (Dark Reader, Clare Chemicals), gels were cut right above the adaptor, and the smear between the adaptor and the well was divided into three even pieces. Each piece was crushed and 1 ml urea gel extraction buffer (0.5 M NH 4 CH 3 CO 2 , 1 mM EDTA, 0.2% SDS) was added. Tubes were rotated for 3-5 h and the suspensions were transferred into SpinX columns (0.2 μ m, acetate; Corning Costar) with a round Whatman filter to prevent membrane clogging. Columns were centrifuged at 14,000g for 1 min. The elutions were combined with 3 μ g polyA carrier RNA, 1 μ l glycogen and 0.7 ml isopropanol. Samples were frozen overnight, centrifuged for 30 min at 14,000g, and DNA pellets were washed with 80% EtOH. Any remaining EtOH was evaporated at 55 °C. Dried pellets were resuspended in 20 μ l H 2 O. For each of the three gel pieces from the same sample, separate PCR reactions, but the same index primer, were used. A 25-cycle PCR was performed at 55 °C annealing and 68 °C extension. Half of each PCR reaction was pooled together and purified with AmpureXP beads (1.8× ratio) according to the manufacturer's instructions. Concentrations were determined using a Qubit Fluorometer (Invitrogen) and the size range was determined by Tapestation (Agilent) measurements. Typical Tapestation gel images showed material between ~150 bp and 500 bp long with two wide peaks at ~160 bp and ~350 bp. On initial library preparation optimization, TopoTA cloning and individual sequencing of 10 or more colonies were performed to check inserts. The final library concentration was adjusted to 4 nM.
MiSeq library runs and data analysis. Libraries were run on an Illumina MiSeq
Benchtop Sequencer using the MiSeq Reagent Kit v3 (150 cycle) and the 'Generate FASTQ' workflow at University College London (UCL) Institute for Neurology Next Generation Sequencing Facility or at the King's College London Genomics Centre. Read lengths were set at 26 bases for Read1 and 142 or 125 bases for Read2. The two libraries from which data are shown in this article had passfilter percentages (PF%) of 93.68% and 93.11% with quality scores (AVG % Q30) of 89.05% and 82.45%, respectively.
The main information extracted from each read included the following. First, we obtained the last nucleotide of the HIV-1 sequence adjacent to the fixed adaptor sequence, which was ligated to the viral cDNAs ( Fig. 1c and Supplementary  Fig. 1b ). This represents the open 3′ -terminus of the viral cDNA at the time of harvest. Second, the base variation of all bases, in particular C to T mutations, was determined. For this purpose FASTQ files were subjected to in-house analysis. Adaptors were trimmed and sequences that were duplicated (including the barcode) were removed as PCR artefacts. The remaining sequences were aligned to the HIV-1 sequence using Bowtie (http://bowtie-bio.sourceforge.net/index.shtml), allowing a maximum of three base mismatches, and the positions of 3′ -termini for each read were determined from the alignment position. Mutation rates from the template sequence for each base were also calculated. Where required, a linear length-dependent correction factor was calculated from the synthesized oligos control library ( Supplementary Fig. 2 ) and applied to the data set to correct for differences in sequencing efficiency of longer products.
Output files for each indexed sample were designed to yield the number of total unique reads for each nucleotide position in the (-)sss product of the HIV-1 NL4.3 proviral sequence. The template that was used spanned the strong stop and first strand transfer sequences up to the polypurine tract (U5-R-U3-PPT; 635 bases total). Of note, only sequences with a minimal length of 22 nt are accounted for in this library due to the primer design. Accordingly, there were 613 possible termini for the cDNA sequences in total, although our main analysis focuses on the 160 nt up to base 182, the strong stop site. For base substitution analysis, parse results presented the number of each of the four possible base calls for each nucleotide position. Percentages could therefore be calculated from the total coverage of each base. Notably, coverage for each base itself is not constant for two reasons: (1) the 3′ -termini of individual reads vary, so coverage ends at varying sites, and (2) the Read2 sequence length of 142 or 125 (depending on the library) may not reach the 5′ end of a strong stop, depending on the starting position.
The relative abundance of cDNA along the (-)sss sequence in the main figures was calculated by dividing the number of total reads for each nt position by the number of total reads up to nt 182 (for total reads see Supplementary Fig. 4b ).
The sole exception is Supplementary Fig. 4a , which shows profiles beyond firststrand transfer, where the read number was divided by the total read count in the entire sample. All figures displaying cDNA profiles (Figs. 1g, 2d and 6e and Supplementary Figs. 2a, 4a, 5 and 7) show the relative abundance of HIV-1 cDNA molecules for each length between nt positions 23 and 182 of the HIV-1 NL4.3 (-)sss product (in blue histogram bars, scale on the left y axes). All positions with cytosine bases in the HIV-1 NL4.3 (-)sss sequence were analysed for the presence of cytosine versus thymine/uracil bases as described above; shown in dashed red lines are the percentages of reads that carried C to T/U mutations at the indicated position (scale on the right y axes). Labels to the right of the graphs describe the virions used for infection.
Co-immunoprecipitation assays. HEK293T cells were transfected in a six-well format using PEI. At 36 h, cells were scraped in ice-cold PBS, pelleted (2 min, 500g) and lysed in DMEM (Gibco) + 0.5% IGEPAL CA 630 (Sigma) plus protease inhibitor cocktail (Roche). After 10 min on ice, cell lysates were sonicated for 10 s and clarified by centrifugation at 100g for 10 min. Magnetic protein G Dynabeads (Invitrogen) were washed twice in PBS using a magnetic stand and then preincubated with FLAG_M2 antibody (Sigma). The charged magnetic beads were washed once, distributed to the different cell lysates and rocked at 4 °C for 2 h. Beads were washed four times with DMEM + 0.5% IGEPAL CA 630, and proteins were then eluted with protein loading buffer (according to Laemmli), resolved by SDS-PAGE and analysed by standard immunoblot analysis. Antibodies used included anti-HA-HRP (3F10, Roche), unconjugated anti-HA (3F10, Roche), anti-FLAG M2-HRP (Sigma), anti-RT (mAb21, NIH AIDS Reagents Repository Program (ARRP)), anti-p24 Gag (mouse monoclonal, 24-2) 76 and anti-GST-HRP (RPN1236, Sigma). Horseradish peroxidase-conjugated primary or secondary antibodies were visualized by enhanced chemiluminescence (Pierce) and
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unconjugated primary antibodies were detected by infrared IRDye-conjugated secondary antibodies (LI-COR Biosciences) and LI-COR infrared imaging technology (LI-COR UK Ltd.) All blots in their uncropped form and including molecular weight markers are presented in Supplementary Fig. 11 .
For co-immunoprecipitation experiments with FLAG_RT and GST_A3G truncations, 50 mM NaCl was added to DMEM + 0.5% IGEPAL CA 630 during washes, for more stringency. Additionally, proteins were eluted after the 2 h incubation by competition with 3xFLAG peptide (150 μ g ml -1 ) for 30 min instead of direct elution by protein loading buffer.
For co-immunoprecipitation coupled with RNase treatment, all starting materials were doubled and the reactions were carried out as above until the 2 h incubation. Magnetic beads were washed twice in DMEM + 0.5% IGEPAL CA 630 and reactions were split into three parts with one part left untreated and RNaseA (Sigma) or RNase Mix (Roche) added to the two remaining reactions at concentrations up to 100 or 20 μ g ml -1 , respectively. All reactions were incubated at room temperature for 30 min while rocking and then washed two more times in DMEM + 0.5% IGEPAL CA 630 before elution in protein loading buffer.
Surface plasmon resonance. Purification of p51 for surface plasmon resonance experiments.
HIV-1 p51 RT was purified from twenty 10 cm dishes of HEK293T cells transfected with p51_FLAG using anti-FLAG magnetic affinity resin (Sigma). Briefly, at 48 h after transfection, cells were lysed in 50 mM Tris HCl 7.6, 150 mM NaCl, 0.5% Triton, 1 mM EDTA supplemented with 50 μ g ml -1 RNase A (Sigma) and protease inhibitor (Roche) and incubated for 10 min on ice. Lysates were sonicated, clarified by centrifugation, and incubated with anti-FLAG M2 magnetic beads (Sigma) for 3 h. The beads were washed extensively with lysis buffer and eluted three times with lysis buffer containing 150 μ g ml -1 3xFLAG peptide (Sigma). Elutions were combined and dialysed against PBS + 0.01% IGEPAL CA 630 (Sigma) to remove the peptides. Samples were concentrated to 10 μ M as determined by Bradford assay, and homogeneity was judged by Coomassie staining ( Supplementary Fig. 8 ).
Surface plasmon resonance experiments. p51_FLAG was diluted to 8 μ M before preparing a twofold dilution series down to 0.16 μ M. A3G was purified as below, dialysed against PBS + 0.01% IGEPAL CA 630 and used at a final concentration of 10 nM. Interaction analyses were performed on a Biacore T200 instrument (GE Healthcare). Binding surfaces for 6xHis tagged A3G were created by immobilizing an anti-His antibody (Biacore/GE Healthcare) onto a Series S CM5 sensor chip surface (Biacore/GE Healthcare) by amine coupling. Capture of the A3G ligand was carried out at low surface density (~200 RU) to minimize potential A3G-A3G interactions and ensure monomeric interactions with p51. The p51 analyte was injected at different concentrations, each in duplicate, in running buffer (PBS + 0.01% IGEPAL CA 630) at 15 μ l min -1 for 4 min followed by a 15 min dissociation time. Standard double referencing data subtraction methods were applied 77 .
FRET detected by FLIM. The interaction between A3G and HIV-1 RT subunits was measured by measuring FRET between fluorescent protein tags on the respective proteins of interest. Energy transfer between fluorescent proteins quickly loses its efficiency as it decreases to the sixth power of distance, and is limited to a distance of less than 10 nm. The detection of FRET suggests the proximity of two fluorophores on the scale of ångstroms 45 . The efficiency of FRET was determined by FLIM, where the fluorescent lifetime refers to the period of time a fluorescent molecule stays in an excited state and emitting a photon. FRET leads to a decrease in the fluorescence lifetime of the donor molecule, and this can be measured very accurately using time-correlated single-photon counting. In contrast to other spectral methods of measuring FRET, such as sensitized emission FRET (SE-FRET or ratiometric imaging) or acceptor photobleaching, the ability to measure the fluorescence lifetime of fluorescent proteins expressed in cells is independent of relative probe concentrations and intensities, as well as being independent of photobleaching and spectral bleedthrough [78] [79] [80] . FLIM is therefore a sensitive and accurate approach to measure FRET between two co-expressed molecules in biological specimens.
Slide preparation. HeLa cells were plated on glass coverslips and transfected using Lipofectamine to express fluorescent fusion proteins. At 24 h later, cells were fixed with 4% paraformaldehyde, washed with PBS, quenched with 1 mg ml -1 sodium borohydride in PBS and mounted using Mowiol (Calbiochem).
For virion samples, a drop of 5 μ g ml -1 fibronectin in PBS was added to coverslips, left for 1 h, removed and allowed to dry before addition of a suspension of sucrose-purified HIV-1 virions (typically 20 μ l at a concentration of an equivalent of 1 × 10 7 pg p24 Gag protein per ml). After 1 h incubation at 37 °C, virions were fixed with 4% paraformaldehyde, quenched, then permeabilized with 0.2% Triton before staining with labelled Fab fragments and mounting. Virions were produced by co-transfection of HEK293T cells with pNL4.3/Δ Vif and expression vectors for fluorescent fusion proteins (A3G, CYPA or Vpr).
Cy3-labelled Fab fragment generation. To obtain RT-specific Fab fragments, we first generated a polyclonal RT-specific antibody in rabbits (with Lampire Biological Laboratories) using full-length RT produced in E. coli. The RT expression plasmid was a gift from S. Hughes and purification was performed as reported in refs 81, 82 . Rabbit serum had titres, as determined by ELISA, of 4.84 × 10 4 and 3.62 × 10 5 at day 30 and 50 post injection, respectively. Antigen-specific antibody was purified from serum by first enriching IgG fractions using Melon Gel IgG purification resin (Pierce) and then binding to full-length RT isolated from HEK293T cells and immobilized using the AminoLink Plus Immobilization Kit (Pierce). Bound antibody was eluted with low pH buffer, neutralized, and subsequently used for Fab fragment preparation and purification using the Fab Micro Preparation Kit (Pierce). The same kit was used to produce Fab fragments from the anti-p24 Gag antibody (mouse monoclonal, 24-2 76 ). All steps were carried out according to the manufacturer's protocol, and the resulting products were controlled by SDS-PAGE and Coomassie staining. Finally, Fab fragments were covalently labelled with Cy3 using Cy3 Monoreactive Dye (GE Healthcare) and purified from excess dye by gel filtration (PD MiniTrap G25, GE Healthcare).
FRET-FLIM instrument. FLIM was used to measure FRET between protein pairs, allowing the determination of spatial protein interactions 83 . Time-domain FLIM was performed with a multiphoton microscope system as described previously [83] [84] [85] . The system is based on a modified Bio-Rad MRC 1024MP workstation, comprising a solid-state-pumped femtosecond Ti:sapphire (Tsunami, Spectra-Physics) laser system, a focal scan-head and an inverted microscope (Nikon TE200). Enhanced detection of the scattered component of the emitted (fluorescence) photons was afforded by the use of fast-response (Hamamatsu R7401-P) non-descanned detectors, developed in-house, situated in the re-imaged objective pupil plane. Fluorescence lifetime imaging capability was provided by time-correlated singlephoton counting (TCSPC) electronics (Becker & Hickl, SPC 700). A × 40 objective was used throughout (Nikon, CFI60 Plan Fluor N.A. 1.3) and data were collected at 500 ± 20 nm through a bandpass filter (Coherent . Images were all acquired at a resolution of 256 × 256 pixels. Laser power was adjusted to give average photon-counting rates on the order of 10 4 -10 5 photons s −1 (0.0001 to 0.001 photon counts per excitation event) to avoid pulse pile up, which can lead to inaccurate lifetime quantification. Acquisition times up to 300 s at low excitation power were used to achieve sufficient photon statistics for monoexponential fitting, while avoiding either pulse pile-up or significant photobleaching. Excitation was at 890 nm. Widefield acceptor images were acquired using a charge-coupled device (CCD) camera (Hamamatsu) at exposure times of < 100 ms.
FRET data analysis. Bulk measurements of FRET efficiency (that is, intensitybased methods) cannot distinguish between an increase in FRET efficiency (that is, coupling efficiency) and an increase in FRET population (concentration of FRET species), because the two parameters are not resolved. The data presented here were analysed using a monoexponential decay model, and goodness of fit was confirmed by determination of chi-squared values close to 1. The FRET efficiency is related to the molecular separation of donor and acceptor and the fluorescence lifetime of the interacting fraction by where R 0 is the Förster radius, r is the molecular separation, η fret is the lifetime of the interacting fraction, and τ d is the lifetime of the donor in the absence of acceptor. η fret and τ d can also be taken to be the lifetime of the interacting fraction and noninteracting fraction, respectively. All data were analysed using TRI2 software (developed by P. Barber, King's College London Figs. 3 and 8) .
UDG functional assay. The efficiency of hUGI-mediated inhibition of cellular UDG activity was evaluated in cell lysates. Cells were lysed by sonication in a buffer containing 10 mM HEPES pH 7.4, 1 mM EDTA and 1 mM DTT. A 34-base, singlestranded uracil-containing oligonucleotide (5′ -attattattattattcugcggatttatttattta-3′ ) 86 was 5′ -end labelled with γ -P 32 -ATP and then incubated with lysate in reaction buffer (10 mM Tris pH 7.4, 1 mM EDTA, 50 mM NaCl). Negative and positive controls comprised the addition of recombinant UDG or UGI (both NEB). Reactions were left for 15 min at 37 °C and stopped by addition of 0.75 volumes of stop buffer (70% formamide, 0.4 N NaOH, 1× TBE). Samples were heated to 95 °C for 15 min, resolved on 8% denaturing urea-polyacrylamide gels, and exposed to a phosphorimaging screen for detection using a Typhoon FLA Biomolecular Imager.
In vitro primer extension assays. Reconstituted primer extension assays were based on a previous method 22 . The HIV-1 RNA template was created using a dsDNA template for in vitro transcription that had been created by PCR using pNL4.3 as the template and the following primers: T7 HIV-1 TAR fwd 5′ -aatttaatacgactcactataggggtctctctggttagaccag-3′ and UL244 rev 5′ -gtcctgcgtcgagagatct-3′ (refs 22, 55 ) . ssRNA was synthesized using the MAXIScript T7 transcription kit (Ambion) according to the manufacturer's protocol, passed through a G-50 column and further purified by denaturing PAGE. An 18 nt DNA oligonucleotide corresponding to the natural HIV-1 primer binding site (5′ -gtccctgttcgggcgcca-3′ ) was radiolabelled using polynucleotide kinase (NEB) and γ -P 32 -ATP (Perkin Elmer). This labelled primer and RNA template were annealed in 50 mM Tris HCl pH 8.0, 75 mM KCl at 65 °C for 5 min followed by gradual cooling to 37 °C, and annealed template/primer was then diluted to 0.1 μ M in reaction buffer (50 mM Tris HCl pH 8.0, 75 mM KCl, 7 mM MgCl 2 , 1 mM DTT). Reactions of 10 μ l were prepared in this buffer with 10 nM template, 200 μ M dNTPs and 1 U μ l -1 RNAase inhibitor (Promega). Reactions were pre-incubated for 10 min at 37 °C with indicated amounts of purified A3G (dialysed against 50 mM Tris HCL pH 8.9, 150 mM NaCl, 10% glycerol, 0.1% NP40, 1 mM DTT) or dialysis buffer alone. Unless otherwise noted, the reactions were initiated by addition of 10 nM HIV-1 RT (Worthington) and incubated for the indicated amount of time at 37 °C. Reactions were stopped with formamide buffer, boiled, and separated on a 6% urea sequencing gel. The gels were dried and exposed to phosphorimager screens for detection using a Typhoon FLA Biomolecular Imager.
Single-molecule RNA binding assay. To quantitatively assess the RNA binding properties of A3G proteins, an assay employing imaging of fluorescently labelled single RNA molecules was carried out as described in ref. 87 . Protein binding increases the fluorescence intensity of the bound ssRNA molecule via a phenomenon referred to as protein-induced fluorescence enhancement (PIFE) 88, 89 . The two ssRNA substrates were purchased from Integrated DNA Technologies: the HIV-1 LTR polyA loop sequence plus linker (5′ -biotinaaaaaaaagccucaauaaagcuugccuugagu-Cy3Sp-3′ ) and an RNA molecule with low predicted secondary structure as used in ref. 86 : (5′ -biotin-auuauuauuauuauuauu auuccgcggauuuauuuauuua-Cy3Sp-3′ ). Briefly, substrates were tethered to a glass surfaces in parallel chambers of flow cells in T-125 buffer (10 mM Tris HCl pH 7.5, 3 mM MgCl 2 , 125 mM NaCl) containing an oxygen scavenging system (1 mg ml -1 of glucose oxidase (Sigma), 0.04 mg ml -1 of catalase (Sigma), 0.4% dextrose) to reduce photobleaching, and 1% β -mercaptoethanol (Acros) serving as a triplet state quencher. A3G and A3G-R24A were purified from insect cells and dialysed against T-125 buffer + 10% glycerol (stocks were 2.5 and 5 μ M, respectively). Proteins were added at concentrations between 100 and 400 nM, and fluorescent intensities of several hundred individual RNA molecules were measured over 2 min. Analysis was performed using in-house software, developed by J. Marko, Northwestern University, which has been described previously 87 and is available upon request.
Bacterial mutator assay. This assay was performed as described in refs 50, 90 . Briefly, pTrc99A-based vectors encoding wild-type or mutant A3G proteins were transformed into E. coli strain KL16. Individual colonies were picked and grown to saturation in Luria broth containing 100 μ g ml -1 ampicillin and 1 mM isopropyl β -d-1-thiogalactopyranoside. Cultures were diluted 1:10, 1:100 or left undiluted, and were spread onto agar plates containing 100 μ g ml -1 rifampicin. The same cultures were also diluted 1:10 6 , 1:10 7 and 1:10 8 onto agar plates containing 100 mg ml -1 ampicillin and incubated overnight at 37 °C. Mutation frequencies were recorded as the number of rifampicin-resistant colonies per 10 9 viable cells, which were enumerated using the ampicillin-containing plates. The experiment was carried out at least twice. To average the repeat experiments, the average colony count for wild-type A3G was set at 100 and all other scores were normalized against this value.
Life Sciences Reporting Summary. Further information on experimental design is available in the Life Sciences Reporting Summary.
Data and code availability. The data supporting this study and custom software are available from the corresponding author upon reasonable request. There are no restrictions to data availability. Raw MiSeq sequencing files analysed in this study (presented in Figs. 1g, 2d and 6e as well as Supplementary Figs. 2, 4 , 5 and 7) are also publicly available at the European Nucleotide Archive (ENA) under study accession no. PRJEB22170. Individual accession codes for each sample are listed in Supplementary Fig. 4b . Custom computer code used to analyse the raw MiSeq reads is deposited in GitHub and is publicly available (http://doi.org/10.5281/ zenodo.1004571).
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Experimental design 1. Sample size
Describe how sample size was determined. Sample size were chosen to provide a minimum of n=5. Exceptions were the deep sequencing libraries. Here, reproducibility of the method was confirmed by 3 full biological replicates of all samples shown in Figure 2 . For further samples (Fig 3 and  8 ) the number of runs in sequencing libraries are indicated in the figure legends.
Data exclusions
Describe any data exclusions.
No full data sets were excluded
Replication
Describe whether the experimental findings were reliably reproduced.
All attempts at replication were successful
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Not relevant to this study. Samples and corresponding controls were always processed at the same time.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
No blinding.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
